• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYNVISC INJECTION; HYALURONIC INJECTION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYNVISC INJECTION; HYALURONIC INJECTION Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problems Arthritis (1723); Hemorrhage/Bleeding (1888); Discomfort (2330)
Event Date 02/01/2014
Event Type  Injury  
Event Description
(b)(6) had 3 injection of (hylan - generic name) in right knee.After third injection, he started complaining about hemorrhoids (external - slight bleeding), lots of discomfort.Started using hemorrhoid cream.Eventually discomfort went way.On list of side effects, hemorrhoids was one of them.Notified dr (b)(6) office and (b)(6) and fda.Lubricant injection for knee) administered by specialist in bone and joint problems.(three injections) 1 a week for 3 weeks.First started taking or using the product: (b)(6) 2014.Stopped taking or using the product: (b)(6) 2014.Arthritis in right knee.This was prepared for you by (b)(6).Hemorrhoids with slight bleeding and discomfort.Hylan provided by (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC INJECTION
Type of Device
HYALURONIC INJECTION
MDR Report Key3717440
MDR Text Key19197744
Report NumberMW5035378
Device Sequence Number1
Product Code MOZ
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other
Type of Report Initial
Report Date 02/23/2014
3 Devices were Involved in the Event: 1   2   3  
1 Patient was Involved in the Event
Date FDA Received03/06/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Patient Sequence Number1
Treatment
ZOLPIDEM 10MG; ARTANE 2MG; SIMVASTATIN 20MG; CLONAZEPAM 0.5; AMANTADINE 100MG; SINEMET 20/100; ROVICET 5MG, 4 X DAY AS NEEDED
Patient Outcome(s) Other;
Patient Age47 YR
Patient Weight102
-
-